Dr Will Stevens
Contact information
Research groups
Will Stevens
BSc, MSc, PhD
Senior Programmer/Analyst
Will is a senior programmer/analyst at the Clinical Trials Services Unit & Epidemiological Studies Unit (CTSU).
He works on software for transforming clinical trial data into a form compliant with standards published by the Clinical Data Interchange Standards Consortium (CDISC). CDISC standards facilitate data sharing and submission of clinical trial data to regulatory agencies. Will has been involved with several CDISC-related groups and committees including the CDISC European Coordinating Committee (E3C) and the CDISC UK Network.
Will has a bachelor’s degree in Computer Science, a master’s degree in Mathematics, and a PhD from the Department of Physics and Astronomy at the Open University. His interests and expertise include: CDISC standards, algorithm development and optimization, software design, testing strategy, efficient use of software and data technologies, multi-paradigm programming. Favourite programming languages: C/C++, Python, SQL, LISP, R.
He joined CTSU in 2013, having previously worked in software design and development for several projects in industry and in academic clinical trials.
Recent publications
Effects of Empagliflozin on Kidney and Cardiac Magnetic Resonance Imaging Measures in Patients With CKD: An EMPA-KIDNEY Mechanistic Substudy.
Journal article
Zhu D. et al, (2025), Am J Kidney Dis
Cost-effectiveness of fenofibrate versus standard care for reducing the progression of diabetic retinopathy: An economic evaluation based on data from the LENS trial.
Journal article
Scotland G. et al, (2025), Diabet Med, 42
Effects of aspirin and omega-3 fatty acids on age-related macular degeneration in ASCEND-Eye: a randomised placebo-controlled trial in a population with diabetes.
Journal article
Sammons E. et al, (2025), BMJ Open, 15
Long-Term Effects of Empagliflozin in Patients with Chronic Kidney Disease.
Journal article
EMPA-KIDNEY Collaborative Group . et al, (2025), N Engl J Med, 392, 777 - 787
SCEND-Eye: Effects of Aspirin on Diabetic Retinopathy.
Journal article
Sammons EL. et al, (2024), Ophthalmology, 131, 771 - 779

